Cytomegalovirus Infection Facilitates the Costimulation of CD57+CD28− CD8 T Cells in HIV Infection and Atherosclerosis via the CD2–LFA-3 Axis
Authors:
- Nicole E WinchesterNWNicole E Winchester
- Soumya PanigrahiSPSoumya Panigrahi
- Xi SuXSXi Su
- Bonnie ChenBCBonnie Chen
- Stephen R. MorrisSMStephen R. Morris
- Steven M. JuchnowskiSJSteven M. Juchnowski
- Raghavendra YadavalliRYRaghavendra Yadavalli
- Francois VillingerFVFrancois Villinger
- Mirko PaiardiniMPMirko Paiardini
- 4 December 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 212 (2) , 245-257
Abstract
CD8 T cells are emerging as important mediators in atherosclerosis and cardiovascular disease (CVD). Immune activation may play a particular role in people with HIV (PWH) who are at an increased risk of CVD, even after controlling for known CVD risk factors. Latent CMV infection is associated with increased CVD risk for both PWH and people without HIV, and human CMV-specific CD4 and CD8 T cells are enriched for an immunosenescent phenotype. We previously showed that CMV coinfection in PWH promotes vascular homing and activation of inflammatory CD4 T cells through the CD2–LFA-3 axis. However, the role of CD2/LFA3 costimulation of CD8 T cells in PWH with CMV has yet to be described. In the present study, we demonstrate that CD2 expression on CX3CR1+CD57+CD28− inflammescent CD8 T cells is increased on cells from CMV-seropositive PWH. In vitro CD2/LFA-3 costimulation enhances TCR-mediated activation of these inflammatory CD8 memory T cells. Finally, we show that LFA-3 is highly expressed in aortas of SIV-infected rhesus macaques and in atherosclerotic plaques of people without HIV. Our findings are consistent with a model in which CMV infection enhances CD2 expression on highly proinflammatory CD8 T cells that can then be stimulated by LFA-3 expressed in the vasculature, even in the absence of CD28 costimulation. This model, in which CMV infection exacerbates toxic cytokine and granzyme production by CD8 T cells within the vasculature, highlights a potential therapeutic target in atherosclerosis development and progression, especially for PWH.Keywords
Funding Information
- HHS | NIH | National Institute of Allergy and Infectious Diseases (AI162150)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (AI167675)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (AI036219)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (AI147821)
- HHS | NIH | NIH Office of the Director (OD011132)
- HHS | NIH | NIH Office of the Director (OD011023)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (AI116171)
- Richard J. Fasenmyer Foundation
This publication has 62 references indexed in Scilit:
- Human T Cell Aging and the Impact of Persistent Viral InfectionsFrontiers in Immunology, 2013
- New insights on the role of CD8+CD57+T-cells in cancerOncoImmunology, 2012
- Cytomegalovirus Immunoglobulin G Antibody Is Associated With Subclinical Carotid Artery Disease Among HIV-Infected WomenThe Journal of Infectious Diseases, 2012
- Cytomegalovirus-Induced Effector T Cells Cause Endothelial Cell DamageClinical and Vaccine Immunology, 2012
- Activation of T Lymphocytes in Atherosclerotic PlaquesArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Semen of HIV-1–Infected Individuals: Local Shedding of Herpesviruses and Reprogrammed Cytokine NetworkThe Journal of Infectious Diseases, 2011
- CD8+ CD28− and CD8+ CD57+ T cells and their role in health and diseaseImmunology, 2011
- Cytomegalovirus-Specific T Cells Persist at Very High Levels during Long-Term Antiretroviral Treatment of HIV DiseasePLOS ONE, 2010
- Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjectsJournal of Experimental Medicine, 2005
- Immune Activation and CD8+ T-Cell Differentiation towards Senescence in HIV-1 InfectionPLOS Biology, 2004